Virax Biolabs signs distribution agreement for Mpox virus detection kits in Europe and Gulf countries.

Virax Biolabs Group Limited (VRAX) signs a distribution agreement with a supplier of RT-PCR Mpox virus detection kits, allowing it to commercialize the kits in European and Gulf countries. The kits, approved for sale in Europe and authorized by the MHRA, deliver results in under 70 minutes with 96.7% sensitivity and 93.72% specificity. VRAX can now import, sell, and distribute Virax-branded Mpox virus Nucleic Acid Detection Kits in regions including the UK, France, Portugal, and GCC nations.

August 28, 2024
150 Articles

Further Reading